Tian Yi Zhang (Tian Zhang, Tian Y Zhang)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Acute Myeloid Leukemia

Systematic Review

Top Venues

Leukemia & lymphoma

Bone marrow transplantation

Science translational medicine

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Yiyu Xie, Vera Kazakova, Lachelle D Weeks, Jonathan M Gerber, Jesse Tai, Tian Yi Zhang, Robert Lowsky, Xiao-Jin Wu, Chengwu Yang, Shyam A Patel
Effects of donor-engrafted clonal hematopoiesis in allogeneic and autologous stem cell transplantation: a systematic review and meta-analysis. Bone marrow transplantation (2024)
Miles H Linde, Amy C Fan, Thomas Kohnke, Aaron C Trotman-Grant, Sarah F Gurev, Paul Phan, Feifei Zhao, Naomi L Haddock, Kevin A Nuno, Eric J Gars, Melissa Stafford, Payton L Marshall, Christopher G Dove, Ian L Linde, Niklas Landberg, Lindsay P Miller, Robbie G Majzner, Tian Yi Zhang, Ravindra Majeti
Reprogramming Cancer into Antigen Presenting Cells as a Novel Immunotherapy. Cancer discovery (2023)
Abdullah Ladha, Gavin Hui, Edna Cheung, Caroline Berube, Steven E Coutre, Jason Gotlib, Michaela Liedtke, Tian Yi Zhang, Lori Muffly, Gabriel N Mannis
Routine use of gemtuzumab ozogamicin in 7 + 3-based inductions for all 'non-adverse' risk AML. Leukemia & lymphoma 62 (6) (2021)
Tian Yi Zhang, Ritika Dutta, Brooks Benard, Feifei Zhao, Raymond Yin, Ravindra Majeti
IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemia. Science translational medicine 12 (538) (2021)
Shyam A Patel, Disha Dalela, Amy C Fan, Maxwell R Lloyd, Tian Yi Zhang
Niche-directed therapy in acute myeloid leukemia: optimization of stem cell competition for niche occupancy. Leukemia & lymphoma (2021)
Armon Azizi, Asiri Ediriwickrema, Ritika Dutta, Shyam A Patel, William Shomali, Bruno Medeiros, David Iberri, Jason Gotlib, Gabriel Mannis, Peter Greenberg, Ravindra Majeti, Tian Yi Zhang
Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience. Leukemia & lymphoma 61 (11) (2020)